The stromal TME composition can be influenced by chemotherapy, resulting in a more aggressive and therapy-resistant tumor state due to contractile CAFs promotion of muscle cell differentiation, T cell activation and tumor cell proliferation. This evidence concerns the gene TBX1 and neoplasm.